Dissecting big pharma's numbers: Pro

In this video

Share

Dissecting big pharma's numbers: Pro

Barbara Ryan, Clermont Partners, breaks down Pfizer and Merck's quarterly results and shares her outlook on the pharmaceutical sector.
03:50
Tue, Jul 28 20157:44 AM EDT